Elan Diagnostics, Inc. ("EDx") (ELN) and Transition Therapeutics Inc. (TTH.TO) Achieve Patient Enrollment Target in Phase 2 Clinical Study of ELND005 (AZD-103) in Alzheimer’s Disease
10/20/2008 10:17:18 AM
More...
|
Boston Biomedical Research Institute And Wyeth (WYE) Announce Licensing Of Alzheimer's Immunotherapy Technology
10/19/2005 5:12:16 PM
More...
|
Eisai Inc. Release: New Data Suggest Zonegran(R) (Zonisamide Capsules) Reduced Seizure Frequency In Pediatric Epilepsy Patients
10/19/2005 5:11:52 PM
More...
|
Elan Corporation PLC (ELN) Dismisses Merger Speculation With Biogen Idec, Inc. (BIIB)
10/19/2005 5:11:51 PM
More...
|